Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Torsades de Pointes | 4 | 2023 | 78 | 2.260 |
Why?
|
| Long QT Syndrome | 4 | 2023 | 472 | 1.660 |
Why?
|
| Anti-Arrhythmia Agents | 8 | 2023 | 775 | 1.530 |
Why?
|
| Potassium Compounds | 2 | 2019 | 42 | 1.210 |
Why?
|
| Ventricular Fibrillation | 3 | 2019 | 537 | 1.190 |
Why?
|
| Tachycardia | 3 | 2015 | 599 | 0.960 |
Why?
|
| Electrocardiography | 13 | 2023 | 6410 | 0.910 |
Why?
|
| Emergency Service, Hospital | 16 | 2018 | 7956 | 0.880 |
Why?
|
| Emergency Medicine | 5 | 2022 | 1222 | 0.830 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2016 | 1041 | 0.820 |
Why?
|
| Confidence Intervals | 2 | 2020 | 2932 | 0.790 |
Why?
|
| Ventricular Premature Complexes | 1 | 2023 | 112 | 0.790 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2020 | 792 | 0.780 |
Why?
|
| Likelihood Functions | 4 | 2015 | 993 | 0.760 |
Why?
|
| Heart Massage | 1 | 2019 | 32 | 0.680 |
Why?
|
| Procainamide | 2 | 2010 | 56 | 0.670 |
Why?
|
| Calcium Compounds | 1 | 2019 | 40 | 0.670 |
Why?
|
| Tachycardia, Ventricular | 4 | 2012 | 1309 | 0.610 |
Why?
|
| Coronary Occlusion | 1 | 2021 | 306 | 0.600 |
Why?
|
| Heart Arrest, Induced | 1 | 2019 | 361 | 0.590 |
Why?
|
| Headache | 2 | 2016 | 1260 | 0.570 |
Why?
|
| Amiodarone | 2 | 2010 | 217 | 0.530 |
Why?
|
| Droperidol | 1 | 2016 | 21 | 0.530 |
Why?
|
| Calcium Chloride | 1 | 2016 | 79 | 0.530 |
Why?
|
| Heart Arrest | 5 | 2019 | 1516 | 0.520 |
Why?
|
| Dangerous Behavior | 1 | 2016 | 65 | 0.510 |
Why?
|
| Hypokalemia | 1 | 2017 | 153 | 0.510 |
Why?
|
| Resuscitation | 2 | 2019 | 680 | 0.490 |
Why?
|
| Narcotics | 1 | 2017 | 337 | 0.480 |
Why?
|
| Spinal Puncture | 2 | 2014 | 286 | 0.460 |
Why?
|
| Methadone | 1 | 2017 | 322 | 0.460 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 997 | 0.390 |
Why?
|
| Hypothermia, Induced | 2 | 2016 | 756 | 0.380 |
Why?
|
| Pneumothorax | 1 | 2015 | 393 | 0.370 |
Why?
|
| Conscious Sedation | 1 | 2016 | 535 | 0.370 |
Why?
|
| Atrial Flutter | 1 | 2013 | 253 | 0.370 |
Why?
|
| Hypotension | 5 | 2021 | 888 | 0.350 |
Why?
|
| Biometry | 2 | 2004 | 565 | 0.350 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 2012 | 425 | 0.340 |
Why?
|
| Heart Conduction System | 1 | 2015 | 1009 | 0.340 |
Why?
|
| Pulmonary Emphysema | 1 | 2015 | 690 | 0.330 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2015 | 559 | 0.320 |
Why?
|
| Cerebral Angiography | 1 | 2014 | 1282 | 0.310 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2015 | 2258 | 0.300 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 1948 | 0.300 |
Why?
|
| Heart Rate | 3 | 2023 | 4218 | 0.290 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1188 | 0.290 |
Why?
|
| Linear Models | 4 | 2014 | 5880 | 0.280 |
Why?
|
| Hyperbilirubinemia | 1 | 2007 | 74 | 0.270 |
Why?
|
| Nitrites | 1 | 2007 | 156 | 0.270 |
Why?
|
| Emergency Treatment | 1 | 2010 | 496 | 0.260 |
Why?
|
| Atrial Fibrillation | 3 | 2023 | 5162 | 0.260 |
Why?
|
| Sepsis | 2 | 2021 | 2602 | 0.250 |
Why?
|
| Adenosine | 1 | 2009 | 816 | 0.230 |
Why?
|
| Swine | 3 | 2019 | 5996 | 0.230 |
Why?
|
| Bundle-Branch Block | 1 | 2005 | 278 | 0.220 |
Why?
|
| Random Allocation | 2 | 2019 | 2399 | 0.220 |
Why?
|
| Sensitivity and Specificity | 6 | 2022 | 14728 | 0.210 |
Why?
|
| Optic Nerve | 3 | 2013 | 572 | 0.200 |
Why?
|
| Aortic Diseases | 1 | 2008 | 742 | 0.190 |
Why?
|
| Sotalol | 1 | 2001 | 47 | 0.180 |
Why?
|
| Dimenhydrinate | 1 | 2000 | 5 | 0.180 |
Why?
|
| GABA Modulators | 1 | 2000 | 109 | 0.180 |
Why?
|
| Urinary Tract Infections | 1 | 2007 | 806 | 0.180 |
Why?
|
| Histamine H1 Antagonists | 1 | 2000 | 101 | 0.170 |
Why?
|
| Infusions, Intravenous | 4 | 2010 | 2228 | 0.170 |
Why?
|
| Chest Pain | 3 | 2015 | 1099 | 0.170 |
Why?
|
| Lorazepam | 1 | 2000 | 155 | 0.170 |
Why?
|
| Bayes Theorem | 2 | 2022 | 2358 | 0.170 |
Why?
|
| Humans | 47 | 2023 | 768451 | 0.170 |
Why?
|
| Anticoagulants | 2 | 2023 | 4840 | 0.160 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1999 | 84 | 0.160 |
Why?
|
| Vertigo | 1 | 2000 | 206 | 0.160 |
Why?
|
| Intracranial Hypertension | 2 | 2013 | 193 | 0.150 |
Why?
|
| Emergency Nursing | 1 | 2018 | 42 | 0.150 |
Why?
|
| Ultrasonography | 6 | 2021 | 5995 | 0.150 |
Why?
|
| Retrospective Studies | 12 | 2023 | 81834 | 0.150 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2007 | 1193 | 0.150 |
Why?
|
| Diagnosis, Differential | 5 | 2015 | 13026 | 0.150 |
Why?
|
| Disease Progression | 1 | 2015 | 13655 | 0.150 |
Why?
|
| Pregnancy, Ectopic | 1 | 1999 | 146 | 0.150 |
Why?
|
| Fluid Therapy | 1 | 2021 | 585 | 0.140 |
Why?
|
| Sample Size | 2 | 2015 | 851 | 0.140 |
Why?
|
| Hospital Charges | 1 | 1999 | 351 | 0.140 |
Why?
|
| Carotid Arteries | 1 | 2021 | 943 | 0.140 |
Why?
|
| Learning Curve | 1 | 2018 | 233 | 0.130 |
Why?
|
| Thermography | 1 | 2016 | 63 | 0.130 |
Why?
|
| Time | 1 | 2017 | 546 | 0.130 |
Why?
|
| Binomial Distribution | 1 | 2015 | 23 | 0.130 |
Why?
|
| Middle Aged | 21 | 2021 | 223418 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 9623 | 0.130 |
Why?
|
| Female | 25 | 2021 | 396943 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 12096 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2023 | 22293 | 0.120 |
Why?
|
| Syndrome | 2 | 2015 | 3278 | 0.120 |
Why?
|
| Sus scrofa | 1 | 2016 | 430 | 0.120 |
Why?
|
| Body Temperature Regulation | 1 | 2016 | 292 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2018 | 346 | 0.120 |
Why?
|
| Lidocaine | 1 | 1997 | 545 | 0.120 |
Why?
|
| Dyspnea | 2 | 2015 | 1352 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2015 | 98 | 0.110 |
Why?
|
| Male | 23 | 2021 | 364781 | 0.110 |
Why?
|
| Intracranial Pressure | 2 | 2013 | 325 | 0.110 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2014 | 117 | 0.110 |
Why?
|
| Least-Squares Analysis | 2 | 2004 | 368 | 0.110 |
Why?
|
| Erythrocyte Count | 1 | 2013 | 157 | 0.100 |
Why?
|
| Coma | 1 | 2016 | 488 | 0.100 |
Why?
|
| ROC Curve | 2 | 2012 | 3624 | 0.100 |
Why?
|
| Point-of-Care Systems | 2 | 2013 | 1228 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 20762 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 1262 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 1519 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2022 | 9687 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2016 | 15460 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2021 | 3839 | 0.080 |
Why?
|
| Single-Blind Method | 2 | 2010 | 1585 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2013 | 1640 | 0.080 |
Why?
|
| Shock, Septic | 1 | 2015 | 774 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2016 | 1795 | 0.080 |
Why?
|
| Meta-Analysis as Topic | 1 | 2013 | 1364 | 0.080 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18388 | 0.080 |
Why?
|
| Nurses | 1 | 2018 | 2494 | 0.080 |
Why?
|
| Atrioventricular Node | 1 | 2009 | 180 | 0.080 |
Why?
|
| Heart | 1 | 2021 | 4451 | 0.070 |
Why?
|
| Prognosis | 2 | 2022 | 30028 | 0.070 |
Why?
|
| Electric Countershock | 2 | 2014 | 534 | 0.070 |
Why?
|
| Hospitals, Urban | 1 | 2010 | 501 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 20231 | 0.070 |
Why?
|
| Aged | 12 | 2021 | 171520 | 0.070 |
Why?
|
| New York | 1 | 2010 | 882 | 0.070 |
Why?
|
| Pulmonary Embolism | 2 | 2012 | 2591 | 0.070 |
Why?
|
| Logistic Models | 2 | 2012 | 13324 | 0.070 |
Why?
|
| Acute Coronary Syndrome | 2 | 2009 | 2195 | 0.060 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1162 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2004 | 6353 | 0.060 |
Why?
|
| Length of Stay | 2 | 2015 | 6521 | 0.060 |
Why?
|
| Teaching Materials | 1 | 2004 | 85 | 0.060 |
Why?
|
| Sodium Channels | 1 | 2005 | 341 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 2 | 2004 | 2705 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2005 | 251 | 0.060 |
Why?
|
| Aortic Aneurysm | 1 | 2008 | 649 | 0.050 |
Why?
|
| Normal Distribution | 1 | 2004 | 272 | 0.050 |
Why?
|
| Oxygen | 1 | 2015 | 4269 | 0.050 |
Why?
|
| Genes, Dominant | 1 | 2005 | 856 | 0.050 |
Why?
|
| Valproic Acid | 1 | 2005 | 443 | 0.050 |
Why?
|
| Hospitalization | 3 | 2023 | 10845 | 0.050 |
Why?
|
| Syncope | 1 | 2005 | 430 | 0.050 |
Why?
|
| Animals | 4 | 2019 | 169418 | 0.050 |
Why?
|
| Critical Care | 1 | 2015 | 2717 | 0.050 |
Why?
|
| Clinical Competence | 4 | 2018 | 4841 | 0.050 |
Why?
|
| Computer Graphics | 1 | 2004 | 338 | 0.050 |
Why?
|
| Risk | 1 | 2014 | 9642 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4861 | 0.050 |
Why?
|
| Adult | 10 | 2014 | 223542 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2017 | 41797 | 0.050 |
Why?
|
| Software | 1 | 2015 | 4463 | 0.050 |
Why?
|
| Sex Factors | 1 | 2015 | 10647 | 0.050 |
Why?
|
| Time Factors | 4 | 2016 | 40271 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1840 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2013 | 3484 | 0.050 |
Why?
|
| Acute Disease | 2 | 2008 | 7246 | 0.040 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2009 | 1751 | 0.040 |
Why?
|
| Risk Factors | 4 | 2017 | 74915 | 0.040 |
Why?
|
| Physician-Patient Relations | 1 | 2013 | 3267 | 0.040 |
Why?
|
| Treatment Outcome | 5 | 2021 | 65409 | 0.040 |
Why?
|
| Prospective Studies | 8 | 2021 | 54914 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 14158 | 0.040 |
Why?
|
| Time and Motion Studies | 1 | 1999 | 143 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2001 | 387 | 0.040 |
Why?
|
| Insurance Claim Reporting | 1 | 1999 | 166 | 0.040 |
Why?
|
| American Heart Association | 1 | 2023 | 1049 | 0.040 |
Why?
|
| Texas | 1 | 1999 | 405 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2021 | 1502 | 0.040 |
Why?
|
| Models, Animal | 1 | 2004 | 2126 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2021 | 1377 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2005 | 1568 | 0.040 |
Why?
|
| Research Design | 1 | 2013 | 6217 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2009 | 4526 | 0.040 |
Why?
|
| Massachusetts | 1 | 2010 | 8908 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5152 | 0.030 |
Why?
|
| Rewarming | 1 | 2016 | 64 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1997 | 1379 | 0.030 |
Why?
|
| Decision Making | 1 | 2009 | 3961 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2018 | 2508 | 0.030 |
Why?
|
| Education | 1 | 2018 | 536 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2016 | 616 | 0.030 |
Why?
|
| Heart Failure | 3 | 2009 | 11857 | 0.030 |
Why?
|
| Reference Values | 2 | 2013 | 4941 | 0.030 |
Why?
|
| Curriculum | 1 | 2007 | 3778 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2005 | 8559 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 10784 | 0.030 |
Why?
|
| Wounds and Injuries | 2 | 2008 | 2518 | 0.030 |
Why?
|
| Walking | 1 | 2000 | 1202 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 4041 | 0.030 |
Why?
|
| Documentation | 1 | 1999 | 913 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2010 | 7451 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39430 | 0.030 |
Why?
|
| Triage | 1 | 1999 | 997 | 0.020 |
Why?
|
| Echocardiography | 1 | 2004 | 5043 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 59680 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2000 | 3577 | 0.020 |
Why?
|
| Sleep | 1 | 2005 | 4796 | 0.020 |
Why?
|
| Brain | 1 | 2016 | 27438 | 0.020 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2008 | 117 | 0.020 |
Why?
|
| Models, Biological | 1 | 2004 | 9505 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2007 | 5952 | 0.020 |
Why?
|
| Blood | 1 | 1990 | 597 | 0.020 |
Why?
|
| Perception | 1 | 2013 | 1207 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2008 | 132 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2000 | 12450 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 36840 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 1999 | 3922 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2014 | 2239 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1990 | 1162 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2009 | 803 | 0.010 |
Why?
|
| Myocardial Infarction | 2 | 2009 | 11515 | 0.010 |
Why?
|
| Observer Variation | 1 | 2009 | 2622 | 0.010 |
Why?
|
| Dissection | 1 | 2004 | 299 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2008 | 1095 | 0.010 |
Why?
|
| Intracranial Hemorrhages | 1 | 2008 | 815 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 30243 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2007 | 1256 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2437 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26351 | 0.010 |
Why?
|
| Urban Population | 1 | 2008 | 2047 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1990 | 3783 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3830 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2014 | 8538 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2009 | 5308 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 8081 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 2785 | 0.010 |
Why?
|
| Pregnancy | 1 | 1999 | 30179 | 0.010 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2001 | 620 | 0.010 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3246 | 0.010 |
Why?
|
| Mathematics | 1 | 1990 | 704 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2009 | 24311 | 0.000 |
Why?
|
| Magnetics | 1 | 1990 | 599 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 89168 | 0.000 |
Why?
|
| United States | 1 | 2007 | 73121 | 0.000 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_